BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3238961)

  • 1. [Broncholytic drug agents in the treatment of dust-induced lung diseases].
    Tolmach DV; Aleksanova AM; Bondarenko GA; Demidov IuL; Taushan MD
    Vrach Delo; 1988 Nov; (11):108-10. PubMed ID: 3238961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of salmeterol on function of bronchi in pneumoconiosis of coal miners].
    Hu JG; Jia W; Hu XW; Wang Y
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Jun; 21(3):233-4. PubMed ID: 14761505
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in diffusion capacity of the lungs during treatment of patients with dust-induced diseases of the broncho-pulmonary system].
    Gladkova EV
    Sov Med; 1973 Jul; 36(7):94-8. PubMed ID: 4776717
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ergometry in assessing the effectiveness of broncholytic preparations in bronchial asthma].
    Eremina SS
    Sov Med; 1978 Apr; (4):138-40. PubMed ID: 349706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Constriction of the respiratory tract and liberation of histamine in byssinosis].
    Bouhuys A; Douglas JS; Hitchcock M
    J Physiol (Paris); 1972 Oct; 65():Suppl:203A-204. PubMed ID: 4119470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of a trial on the spirometric and associated effects of a new bronchodilator, C 325 (author's transl)].
    Minette A; Marcq M; Bruninx M
    Acta Tuberc Pneumol Belg; 1974; 65(5):520-33. PubMed ID: 4466343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences in the treatment of bronchopulmonary diseases especially those caused by silicosis].
    Volk R
    Zentralbl Arbeitsmed; 1967 Aug; 17(8):229-34. PubMed ID: 5589657
    [No Abstract]   [Full Text] [Related]  

  • 8. [Broncholytic inhalation therapy. Double-blind study hexoprenaline orziprenaline in chronic obstructive respiratory tract diseases].
    Debelić M
    Schweiz Med Wochenschr; 1974 Sep; 104(38):1321-6. PubMed ID: 4608626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Function of external respiration in patients with tuff-induced pneumoconiosis].
    Eramian SG; Dashtoian AK; Sungurian NN
    Gig Tr Prof Zabol; 1974 Apr; 18(4):49-51. PubMed ID: 4845009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ventilatory effect and side effects of oral bamifylline].
    Minette A
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):211-21. PubMed ID: 552146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory mechanics and dust exposure in byssinosis.
    Bouhuys A; Van de Woestijne KP
    J Clin Invest; 1970 Jan; 49(1):106-18. PubMed ID: 5409799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the treatment of bronchial asthma and asthmoid states in the office practice].
    Leitloff H
    Hippokrates; 1966 May; 37(9):360-3. PubMed ID: 5984961
    [No Abstract]   [Full Text] [Related]  

  • 14. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
    Muittari A; Mattila MJ; Tiitinen H
    Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of broncholytic preparations in bronchial asthma in children].
    Ardashnikova SN; Koval'kova OS
    Med Sestra; 1987 Aug; 46(8):37-40. PubMed ID: 3695869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment and status of the external respiratory function in dust-induced diseases of the bronchopulmonary apparatus].
    Penknovich AA; Faerman IS; Gladkova EV
    Gig Tr Prof Zabol; 1970 Nov; 14(11):7-10. PubMed ID: 5501832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment possibilities and treatment results in pneumoconioses].
    Ulmer WT
    Schweiz Med Wochenschr Suppl; 1983; 15():47-50. PubMed ID: 6582595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-experimental contribution to the method of pneumometric testing of broncholytic drugs].
    Zidek R
    Med Klin; 1965 Sep; 60(37):1498-502. PubMed ID: 5862105
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correction of acid-base equilibrium as a therapeutic factor in dust-induced diseases].
    Nargizian GA; Avakian MA; Melik-Israelian SS
    Zh Eksp Klin Med; 1976; 16(2):82-7. PubMed ID: 973508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous immunoglobulin infusion treatment for pneumoconiosis complicated with severe asthma in coal miners ].
    Zhao JN; Wang P
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Jun; 21(3):234-5. PubMed ID: 14761506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.